The Marcus (MCS) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for May 7, 2025, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials and annual report before voting.
Voting matters and shareholder proposals
Election of ten directors is on the agenda, with all nominees recommended by the board.
Approval of the 2025 Omnibus Incentive Plan is proposed.
Advisory vote on executive compensation (say-on-pay) is included.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2025.
Board of directors and corporate governance
Ten director nominees are listed for election at the annual meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from The Marcus
- 2025 revenue reached $758.5M with strong theatre and hotel performance and robust growth outlook.MCS
Investor presentation5 Mar 2026 - Both divisions outperformed their industries, with strong revenue growth and a robust 2026 outlook.MCS
Q4 202526 Feb 2026 - Q2 revenue dropped 15%, but hotels outperformed and group bookings surged as theatres rebounded.MCS
Q2 20242 Feb 2026 - Record Q3 revenue, earnings, and industry outperformance with a strengthened capital structure.MCS
Q3 202417 Jan 2026 - Q4 revenue up 16.6% and record hotel results, with strong momentum for 2025 growth.MCS
Q4 202423 Dec 2025 - Shelf registration enables up to $150M in securities offerings and 5M-share secondary sales.MCS
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, incentive plan, executive pay, and auditor ratification.MCS
Proxy Filing2 Dec 2025 - Q1 revenue up 7.4%, but net loss widened to $16.8M; strong outlook for films and hotels.MCS
Q1 202519 Nov 2025 - Q2 2025 revenue up 17%, profit returns, theatres lead growth, CapEx to decline post-2025.MCS
Q2 202516 Nov 2025